Nalaganje...
Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia
BACKGROUND: The granulocyte-colony stimulating factor (G-CSF) biosimilar filgrastim (Nivestim™) reduces the duration and severity of neutropenia and the frequency of occurrence of febrile neutropenia (FN). Administration of this biosimilar filgrastim and the patient population receiving it at home h...
Shranjeno v:
| izdano v: | Patient Prefer Adherence |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6199230/ https://ncbi.nlm.nih.gov/pubmed/30410313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S168029 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|